Oral Administration of Gemcitabine in Patients with Refractory Tumors: A Clinical and Pharmacologic Study

S. A. Veltkamp, R. S. Jansen, S. Callies, D. Pluim, C. M. Visseren-Grul, H. Rosing, S. Kloeker-Rhoades, V. A.M. Andre, J. H. Beijnen, C. A. Slapak, J. H.M. Schellens
  • Clinical Cancer Research, June 2008, American Association for Cancer Research (AACR)
  • DOI: 10.1158/1078-0432.ccr-07-4521

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Robert Jansen